Mispro Launches Insourcing Services for Vivarium Research Facilities

Apr 23, 2019

iTeos Therapeutics Initiates Phase 1/1b Trial with Differentiated Adenosine A2A Antagonist in Patients with Advanced Cancer

Apr 17, 2019

The Carolyn E. Green Scholarship: Leadership Opportunities for Women in Life Science

Apr 13, 2019

Posted by Halloran Consulting Group, A PLG Company

WCG Expands its Research Site Executive Team, Global Research Network

Apr 12, 2019

Protagen Protein Services and BioAnalytix Merge to Create Global Analytic Service Partner for Biopharmaceuticals

Apr 11, 2019

Posted by ProtaGene

Queensland Biomedical Voucher Program

Apr 09, 2019

Queensland Biomedical Voucher Program

Apr 09, 2019

CONSILIUM STRATEGIC COMMUNICATIONS EXPANDS INTO US AND BROADENS ITS STRATEGIC HEALTHCARE COMMUNICATIONS OFFERING

Apr 08, 2019

WCG Announces the Acquisition of Analgesic Solutions, LLC

Apr 04, 2019

NANOBIOTIX ANNOUNCES FIRST EVER RADIOENHANCER TO RECEIVE EUROPEAN MARKET APPROVAL

Apr 04, 2019

Posted by Nanobiotix

Combination of first-in-class NBTXR3, radiotherapy, and anti-PD-1 immunotherapy demonstrate efficacy in treating resistant pre-clinical in vivo models of lung cancer

Apr 03, 2019

Posted by Nanobiotix

Charles River Laboratories Highlights Commitment to Oncology Research at 2019 AACR Annual Meeting

Apr 02, 2019

Posted by Charles River Laboratories